Avalide and Phenergan drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Avalide (hydrochlorothiazide; irbesartan) and Phenergan (promethazine hydrochloride). Common drug interactions include pleural effusion among females and dehydration among males.

The phase IV clinical study analyzes what interactions people have when they take Avalide and Phenergan. It is created by eHealthMe based on reports of 61 people who take the same drugs from the FDA, and is updated regularly.

What is Avalide?

Avalide has active ingredients of hydrochlorothiazide; irbesartan. It is often used in high blood pressure. eHealthMe is studying from 5,943 Avalide users. Check the latest studies of Avalide.

What is Phenergan?

Phenergan has active ingredients of promethazine hydrochloride. It is often used in nausea. eHealthMe is studying from 25,312 Phenergan users. Check the latest studies of Phenergan.



On Aug, 05, 2026

61 people who take Avalide and Phenergan together, and have interactions are studied.

Avalide and Phenergan drug interactions.

What are the common drug interactions of Avalide and Phenergan, by gender? *:

female:

  1. Pleural effusion (water on the lungs)
  2. Arthralgia (joint pain)
  3. Fall
  4. Blood alkaline phosphatase increased
  5. Nasal congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels)
  6. Productive cough
  7. Back pain
  8. Decreased appetite
  9. Metastases to bone (cancer spreads to bone)
  10. Osteonecrosis of jaw (death of bone of jaw)

male:

  1. Dehydration (dryness resulting from the removal of water)
  2. Fall
  3. Hemiparesis (weakness on one side of the body)
  4. Hyperlipidaemia (presence of excess lipids in the blood)
  5. Hypokalaemia (low potassium)
  6. Lethargy (tiredness)
  7. Oral intake reduced
  8. Pneumonia
  9. Activities of daily living impaired
  10. Bursitis (inflammation of a bursa, typically one in the knee, elbow, or shoulder)

What are the common drug interactions of Avalide and Phenergan, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Anaemia (lack of blood)
  3. Angina pectoris (chest pain due to ischemia of the heart muscle)
  4. Aortic valve incompetence
  5. Asthenia (weakness)
  6. Asthma
  7. Bronchitis acute (acute inflammation of the mucous membrane in the bronchial tubes)
  8. Chest pain
  9. Decreased appetite
  10. Depression

40-49:

  1. Anxiety
  2. Pain in extremity
  3. General physical health deterioration (weak health status)
  4. Pain
  5. Diarrhoea
  6. Headache (pain in head)
  7. Rash
  8. Sinusitis (inflammation of sinus)
  9. Abdominal discomfort
  10. Anaemia (lack of blood)

50-59:

  1. Nasal congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels)
  2. Neck pain
  3. Oesophageal candidiasis (fungal infection of oesophagus)
  4. Oesophageal stenosis (narrowing of oesophagus)
  5. Oral candidiasis (fungal infection of mouth)
  6. Osteoporosis (bones weak and more likely to break)
  7. Pericardial effusion (fluid around the heart)
  8. Productive cough
  9. Pulmonary hypertension (increase in blood pressure in the lung artery)
  10. Rhinitis allergic (inflammation of the nasal airways due to allergy)

60+:

  1. Pyrexia (fever)
  2. Dehydration (dryness resulting from the removal of water)
  3. Atelectasis (partial or complete collapse of the lung)
  4. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  5. Bile duct obstruction (blockage in the tubes that carry bile from the liver to the gallbladder)
  6. Cardiovascular disorder (heart diseases)
  7. Death
  8. Decreased activity
  9. Depressed level of consciousness
  10. Drug toxicity

What are the existing conditions these people have? *

  1. Glioblastoma Multiforme (most common and deadliest of malignant primary brain tumours in adults): 11 people, 18.03%
  2. Pain: 8 people, 13.11%
  3. Breast Cancer Metastatic: 7 people, 11.48%

* Approximation only. Some reports may have incomplete information.

Do you take Avalide and Phenergan?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Avalide and Phenergan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Avalide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Phenergan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Avalide and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Phenergan and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on hydrochlorothiazide; irbesartan and promethazine hydrochloride (the active ingredients of Avalide and Phenergan, respectively), and Avalide and Phenergan (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: